A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate | Citedby Results | Hormone Research in Paediatrics | Karger Publishers

Skip to Main Content

Skip Nav Destination

A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate

Horm Res Paediatr (2016) 86 (3): 188–195.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Efficacy of leuprolide acetate versus triptorelin pamoate administered every 3 months for treatment of central precocious puberty

Thanaporn Thaneetrakool
Suphab Aroonparkmongkol
Nattakarn Numsriskulrat
Vichit Supornsilchai
Suttipong Wacharasindhu
Khomsak Srilanchakon

Clinical and Experimental Pediatrics (2025) 68 (1): 91.

A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty

Xiao Yu
Xinran Cheng
Haiyan Wei
Xu Xu
Chunxiu Gong
Guimei Li
Hui Yao
Li Zhou
Yan Zhong
Yu Yang
Feihong Luo
Yining Zhang
Frank Huang
Xiaofeng Shi
Patrick Cabri
Xiaoping Luo

Advances in Therapy (2024) 41 (12): 4537.

The Impact of Temperature on the Formation, Release Mechanism, and Degradation of PLGA-based In-Situ Forming Implants

Kimia Shafiee
Saeid Bazraei
Arezou Mashak
Hamid Mobedi

Journal of Polymers and the Environment (2024) 32 (8): 3591.

Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study

Xiaoping Luo
Cai Zhang
Yu Yang
Xu Xu
Xinran Cheng
Haiyan Wei
Lanying Wang
Frank Huang
Xiaofeng Shi
Patrick Cabri

Advances in Therapy (2023) 40 (10): 4574.

Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study

Jianmei Yang
Qijun Song
Shuo Gao
Yuye Gao
Xiaohong Shang
Guimei Li
Yan Sun
Xiaoping Luo
Per Hellström

International Journal of Endocrinology (2022) 2022: 1.

Effectiveness of basal LH in monitoring central precocious puberty treatment in girls

Valeria Calcaterra
Gianpaolo De Filippo
Riccardo Albertini
Domenico Rendina
Beatrice Messini
Claudio Maria Monti
Elena Bozzola
Alberto Villani
Mauro Bozzola

Journal of Pediatric Endocrinology and Metabolism (2021) 34 (1): 45.

Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center

Lindsey Yoojin Chung
Eungu Kang
Hyo-Kyoung Nam
Young-Jun Rhie
Kee-Hyoung Lee

Journal of Korean Medical Science (2021) 36 (34)

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty

Karen O Klein
Analía Freire
Mirta Graciela Gryngarten
Gad B Kletter
Matthew Benson
Bradley S Miller
Tala S Dajani
Erica A Eugster
Nelly Mauras

The Journal of Clinical Endocrinology & Metabolism (2020) 105 (10): e3660.

Comparison of triptorelin acetate vs triptorelin pamoate in the treatment of Central precocious puberty (CPP): a retrospective study

Stefania Lasorella
Rossella Porto
Maria Laura Iezzi
Carmelo Pistone
Gian Luigi Marseglia
Alberto Verrotti
Ilaria Brambilla

Gynecological Endocrinology (2020) 36 (4): 338.

Novel triptorelin acetate-loaded microspheres prepared by a liquid/oil/oil method with high encapsulation efficiency and low initial burst release

Liqing Chen
Atef Mohammed Qasem Ahmed
Yibin Deng
Dingyun Cao
Huanhuan Du
Jinghao Cui
Beom-Jin Lee
Qingri Cao

Journal of Drug Delivery Science and Technology (2019) 54: 101390.

Triptorelin depot for the treatment of children 2 years and older with central precocious puberty

Silvano Bertelloni
Cristina Mucaria
Giampiero I. Baroncelli
Diego Peroni

Expert Review of Clinical Pharmacology (2018) 11 (7): 659.

Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation

Adélaïde Durand
Maithé Tauber
Bharat Patel
Pascale Dutailly

Hormone Research in Paediatrics (2017) 87 (4): 224.